bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.09.14.508058

Does ivermectin treatment for endemic hookworm infection alter the gut microbiota of endangered Australian sea lion pups?

Abstract

The gut microbiota is essential for the development and maintenance of the hosts immune system, and disturbances can impact host health. This study aimed to determine if topical ivermectin treatment for endemic hookworm (Uncinaria sanguinis) infection in Australian sea lion (Neophoca cinerea) pups causes gut microbial changes. The gut microbiota was characterised for untreated (control) (n=23) and treated (n=23) pups sampled during the 2019 and 2020/21 breeding seasons at Seal Bay, Kangaroo Island. Samples were collected pre- and post-treatment on up to four occasions. The gut microbiota of both untreated (control) and treated pups was dominated by five bacterial phyla, Fusobacteria, Firmicutes, Proteobacteria, Actinobacteria and Bacteroides. There was a significant difference in alpha diversity between treatment groups in 2020/21 (p = 0.008), with greater diversity in treated pups. Modelling the impact of host factors on beta diversity revealed that pup ID accounted for most of the variation with pup ID, age and capture being the only significant contributors to microbial variation (p < 0.05). There were no statistically significant differences in microbial composition between treatment groups in both breeding seasons, indicating that ivermectin treatment did not alter microbial composition. To our knowledge, this is the first study to consider the impact of parasitic treatment on overall diversity and composition of the gut microbiota. Importantly, the lack of compositional changes in the gut microbiota with topical treatment support the utility of topical ivermectin as a safe and minimally invasive management strategy to enhance pup survival in this endangered species. ImportanceDisturbances to the gut microbiota in early life stages can have life-long impacts on host health. Australian sea lions are endangered and declining, and pups are endemically infected with hookworm (Uncinaria sanguinis) which contributes to pup mortality. Treatment with topical ivermectin has been shown to effectively eliminate hookworm infection and to improve pup health, but the impact on the gut microbiota was previously unknown, representing a key knowledge gap. The results from this study show that topical ivermectin treatment does not alter the gut microbiota of Australian sea lion pups, indicating that it is a safe and minimally invasive treatment that can aid in disease mitigation and conservation of this endangered species.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Fulham, M., Power, M. L., Gray, R.. 2022-09-15. Does ivermectin treatment for endemic hookworm infection alter the gut microbiota of endangered Australian sea lion pups?. https://doi.org/10.1101/2022.09.14.508058

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Microbially conjugated bile acids differentially affect the lifecycle and pathogenesis of Clostridioides difficile

Clostridioides difficile is a Gram-positive bacterium that causes C. difficile infection (CDI). In healthy adults, it has been proposed that the gut microbiota provides colonization resistance against C. difficile by competition through nutrient limitation and antagonism through secondary bile acid metabolism, the latter of which is mediated by the deconjugation of host-derived bile acids with bacterial bile salt hydrolases (BSH). Recently, BSHs have also shown an ability to reconjugate non-canonical (i.e., not glycine or taurine) amino acids to sterol cores, resulting in novel microbially conjugated bile acids (MCBAs). MCBAs have been associated with the resolution of recurrent CDI, though the mechanism underlying these effects are not well understood. To address this gap, we synthesized 36 MCBAs with nine amino acids (cysteine, isoleucine, leucine, phenylalanine, proline, serine, tryptophan, tyrosine, and valine) conjugated to the primary and secondary bile acids found in the human gut (CA, DCA, CDCA, and LCA) and tested their impact on various stages of C. difficiles lifecycle including bacterial outgrowth, membrane integrity, sporulation, and toxin activity. We show that BSH-mediated amidation of bile acid sterol cores can either increase or decrease inhibitory effects on C. difficile in an amino acid-dependent manner. For example, serine MCBAs enhanced C. difficiles ability to grow in otherwise inhibitory bile acid concentrations, increased spore production, and elevated toxin activity. Tryptophan MCBAs increased inhibition. By demonstrating these variable effects, our work clarifies the molecular determinants of MCBA activity and highlights specific MCBAs as promising targets for the development of C. difficile microbial-based therapeutics.

microbiology↗

Magnetic organelle gene clusters enable bacterial growth and ATP homeostasis under oxidizing conditions

Biological organisms can produce magnetic nanoparticles made of magnetite to detect the Earth's magnetic field for orientation. The evolutionary mechanisms that led to the acquisition of this capacity remain unknown. The most ancient organisms known to perform magnetic orientation are magnetotactic bacteria. Under tight genetic control, they produce chains of magnetite nanoparticles in dedicated organelles to allow efficient navigation in aquatic environments containing molecular oxygen. Yet, these bacteria have been proposed to emerge before molecular oxygen became abundant on Earth, at a time when this navigation system could not have served its current function. Here, we show that gene clusters responsible of magnetite formation and organization enable resistance against hydrogen peroxide, a toxic oxygen-derived compound that was produced during the early stages of Earth's oxygenation when iron oxidation consumed molecular oxygen. Characterization of the nanoparticle's oxidation state supported the involvement of magnetite in resistance to hydrogen peroxide-induced oxidative stress. These findings are compatible with an early emergence of magnetotactic bacteria, before natural waters became oxygenated. We propose a conceptual framework to explain the origin of magnetic orientation in bacteria, and offer tools to identify the initiation of Earth's oxygenation in a time-resolved manner.

microbiology↗

Identification and characterization of new P. aeruginosa phages using a surface receptor platform

Bacteriophages are of increasing interest for their potential use as alternatives to antibiotics for treating drug-resistant infections. Phage steering, specifically receptor-based steering, involves use of phages that bias the development of resistance in bacteria towards phenotypes such as reduced fitness. Phage therapy typically involves administering cocktails of phages with different targets to reduce the likelihood of resistance emerging. To ensure effective steering and cocktail design, there is a need to identify the receptors used by phages of interest, and to isolate phages that use diverse receptors. Here we describe a SURFAce Receptor (SURFAR) platform consisting of a set of defined Pseudomonas aeruginosa strains and mutants for rapid characterization of phage receptors. This platform can also be used to enrich for and isolate diverse phages from environmental samples, yielding novel phage genomes from wastewater. Using the SURFAR platform, two new phages were isolated and characterized: Dalewood, which targets both flagella and the conserved LPS outer core, and Bowman, a biofilm targeting phage capable of supressing growth of a subset of carbapenem-resistant clinical isolates. This tool helps to standardize the laborious but important task of phage receptor characterization, with the goal of expanding the known repertoire of P. aeruginosa phage receptors and phages.

microbiology↗